FourThought Financial’s Biogen BIIB Stock Holding History

FourThought Financial’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$5K	Sell	18 -103	-85%	-$21.9K	﹤0.01%	1162
2022 Q2	$25K	Sell	121 -7	-5%	-$1.43K	﹤0.01%	808
2022 Q1	$27K	Hold	128	–	–	﹤0.01%	827
2021 Q4	$31K	Sell	128 -4	-3%	-$1.03K	﹤0.01%	808
2021 Q3	$37K	Hold	132	–	–	﹤0.01%	774
2021 Q2	$45K	Sell	132 -1,060	-89%	-$321K	0.01%	738
2021 Q1	$333K	Sell	1,192 -359	-23%	-$96.8K	0.05%	270
2020 Q4	$379K	Buy	+1,551	New	+$400K	0.06%	242

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

FourThought Financial's BIIB Position: Q3 2022 in Review

FourThought Financial reduced its Biogen (BIIB) stake by 85% in Q3 2022, selling an estimated $21.9K and leaving 18 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #1162.

FourThought Financial first reported a position in BIIB in Q4 2020 and has held it in 8 quarters since. The position peaked at $379K in Q4 2020. 987 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.

FourThought Financial held 18 shares of Biogen worth $5K as of Q3 2022.
FourThought Financial sold 103 Biogen shares in Q3 2022, an estimated $21.9K.
Biogen made up ﹤0.01% of FourThought Financial's portfolio in Q3 2022, its #1162 holding.
FourThought Financial first reported a position in Biogen in Q4 2020 and has held it in 8 quarters since.
FourThought Financial's Biogen position peaked at $379K in Q4 2020.
987 funds tracked by Wall St. Rank held Biogen as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.